Navigation Links
Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
Date:9/5/2007

and obtaining the approvals required to make picoplatin available to this severely underserved patient population."

About Fast Track Designation

The fast track programs of the FDA are designed to facilitate the development and expedite the review of drugs and biologics that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast track designation enables the product candidate to become approved and reach the market expeditiously. This may include priority review (i.e., six-month versus the standard ten-month review) and the option to submit a New Drug Application on a rolling basis, enabling FDA to begin reviewing sections of the application before receiving the complete application. According to the FDA, picoplatin is eligible for Fast Track designation due to the unmet medical need -- with no approved therapy for refractory disease, responses seen in two Phase 2 studies, and Poniard's randomized, controlled Phase 3 trial of picoplatin and best supportive care (BSC) versus BSC alone.

About Picoplatin

Picoplatin is a new generation platinum chemotherapy agent. It was designed to overcome platinum resistance and to prolong the time to relapse after chemotherapy in the treatment of solid tumors, and to have an improved safety profile compared with existing platinum-based chemotherapeutics. Poniard received orphan drug designation from the FDA in November 2005 for picoplatin for the treatment of SCLC.

In addition to the SPEAR trial of intravenous picoplatin in SCLC, Poniard is also evaluating intravenous picoplatin in an ongoing Phase 1 clinical trial as a first-line treatment for metastatic colorectal cancer and in an ongoing Phase 2 trial in combination with docetaxel (Taxotere(R)) and prednisone in patients with metastatic hormone-refractory prostate cancer. Oral picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors.

About Small Cell
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Lazarus Effect, a ... novel interventional devices to facilitate removal of blood ... and Trademark Office has issued a new patent ... the company,s Lazarus Cover TM and ReCover ... ReCover is a single-component stent-retriever (stentriever) with an ...
(Date:7/24/2014)... -- Decision Resources Group finds that, for the treatment ... France , Germany , ... and the United Kingdom ) hold ... beta2 agonist/inhaled corticosteroid (LABA/ICS) fixed-dose combination (FDC), Relvar (GlaxoSmithKline/Theravance). ... first-line LABA/ICS FDC in the treatment of asthma with ...
(Date:7/24/2014)... DALLAS , July 24, 2014 /PRNewswire-iReach/ -- ... days once order is placed. Photo ... is a professional and in-depth market survey on ... firstly reviews the basic information of Hemodialysis Machine ... report then explores global and China,s top manufacturers ...
Breaking Medicine Technology:Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5
... , SAN DIEGO , May 6 An innovative ... breath and fluid overload as the result of a severely leaky heart ... study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) ... , , ...
... and ATLANTA , May 6 Swedish ... finalized a strategic partnership to launch a major new cancer-care ... unique, multi-year, multi-product collaboration covers the spectrum of cancer management ... workflow and connectivity – and enhances Swedish Cancer Institute,s ...
Cached Medicine Technology:MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 3MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 4Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond 2Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond 3Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond 4Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond 5Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond 6
(Date:7/24/2014)... Medicine researchers may have found a way to delay ... pre-treatment of neurons with the anti-aging protein Klotho can ... amyloid protein and glutamate. These findings currently appear in ... Alzheimer,s disease is the most frequent age-related dementia affecting ... 65 and older and more than 40 percent of ...
(Date:7/24/2014)... 2014 (HealthDay News) -- Drinking caffeine may worsen the ... of women as they go through menopause, new survey ... study suggests that limiting caffeine intake may be useful ... and night sweats," said researcher Dr. Stephanie Faubion, director ... in Rochester, Minn. But caffeine -- a stimulant ...
(Date:7/24/2014)... Hospital and the University of Tennessee Health Science Center ... drug shown to safely reduce the viral load and ... respiratory syncytial virus (RSV). RSV is the most common ... in the United States and worldwide. , The ... John DeVincenzo, MD. DeVincenzo,s Le Bonheur lab has been ...
(Date:7/24/2014)... 2014 As the age of marriage ... freezing as a way to ensure future family building ... with advancing reproductive age. Vitrification technology, a fast freeze ... medical technology that allows a woman to have multiple ... years, which are then stored for future use. When ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 In a recent ... States has officially put an end to criminal penalties associated ... a new era for marijuana reform in Washington DC, giving ... The new law replaces criminal penalties for possession of one ... selling and the possession of more than an ounce of ...
Breaking Medicine News(10 mins):Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:RSV research breakthrough to help infected children 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Washington D.C. Decriminalizes Marijuana 2
... (August 12, 2010) Once thought to be a problem primarily ... death and disability,in poorer countries. Almost two-thirds of the 7.6 ... countries. A paper to be published online in the ... community must now discard the notion that cancer is,a ,disease ...
... The context in which adolescent sexual activity occurs ... intercourse and education, according to research to be ... American Sociological Association. "Compared to abstinence, sexual ... harmless, whereas in other types of relationships it ...
... suffer in childhood can lead to weakened immune systems later ... this new research, the amount of this immune impairment even ... life. "What happens in childhood really matters when it ... your life," explained Janice Kiecolt-Glaser, professor of psychology and psychiatry ...
... not increase lung cancer mortality in postmenopausal women, according ... The Journal of the National Cancer Institute. ... consisted of several clinical trials on postmenopausal women, one ... plus progestin therapy had a statistically significant increase in ...
... HealthDay Reporter , FRIDAY, Aug. 13 (HealthDay News) ... acetaminophen, best known as Tylenol, were more than twice ... take the over-the-counter pain and fever reducer, new research ... increased chance of eczema and rhinoconjunctivitis, or allergic nasal ...
... patient,s blood or bone marrow that nourish blood vessels may ... cardiovascular disease than obtaining rare stem cells, according to research ... trials, doctors in several countries have tested the ability of ... heart attacks and peripheral artery disease, created by problems of ...
Cached Medicine News:Health News:Global health leaders advocate for expanding cancer care in developing countries 2Health News:Global health leaders advocate for expanding cancer care in developing countries 3Health News:Sex between adolescents in romantic relationships is often harmless to their academics 2Health News:Childhood abuse, adversity may shorten life, weaken immune response among the elderly 2Health News:Childhood abuse, adversity may shorten life, weaken immune response among the elderly 3Health News:Estrogen not associated with lung cancer incidence and mortality among postmenopausal women 2Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 2Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 3Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 4Health News:Selected cells from blood or bone marrow may provide a route to healing blood vessels 2Health News:Selected cells from blood or bone marrow may provide a route to healing blood vessels 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: